3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1
1
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Pancreatic Neoplasms
2
Duodenal Neoplasms
1
Cholangiocarcinoma
1
Bile Duct Neoplasms
1
Anastomotic Leak
1
Interventions
Oxaliplatin
300
Fluorouracil
272
Bevacizumab
237
Gemcitabine
236
Leucovorin
212
Capecitabine
207
pembrolizumab
201
Nivolumab
158
Irinotecan
158
Cisplatin
150
Specimen Handling
144
Magnetic Resonance Spectroscopy
130
130-nm albumin-bound paclitaxel
118
Paclitaxel
109
durvalumab
107
Cetuximab
104
Radiotherapy
99
atezolizumab
94
Drug Therapy
94
Biopsy
93
tislelizumab
81
Albumin-Bound Paclitaxel
81
Taxes
74
Folfox protocol
68
lenvatinib
67
Carboplatin
66
regorafenib
60
Blood Specimen Collection
60
sintilimab
54
Ipilimumab
53
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Tissue Adhesives
×
Gastrointestinal
×
1 year
×
Clear all
NCT07155525
2025-09-18
NBCA-MS
Minia University
Phase 3
Recruiting
194 enrolled
NCT07132541
2025-09-02
NBCA
Minia University
Phase 1
Recruiting
30 enrolled